Tamsulosin (Urimax) In Female Patient: A Case of Recurrent UTI and Left Pelvic Calculi

Tamsulosin hydrochloride is a selective α1A-adrenergic receptor antagonist commonly used in the treatment of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland that can impede normal urinary flow in men. By selectively blocking α1A receptors predominantly located in the smooth muscle of the prostate and bladder neck, tamsulosin relaxes these muscles, thereby improving urine flow and reducing symptoms of urinary obstruction. Administered orally, typically in extended-release formulations, tamsulosin is well-tolerated, with common side effects including dizziness, abnormal ejaculation, and rhinitis. It is metabolized primarily by the liver via cytochrome P450 enzymes and excreted in the urine. By relaxing the smooth muscles in the urethral and bladder neck, tamsulosin can be used off-label to treat voiding dysfunctions in females, such as LUTS (Lower urinary tract symptoms), BOO (Bladder outlet obstruction), or urinary retention. It should be used on an individual basis and is frequently saved for particular situations when there aren't many other options.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-09-27
DOI
https://doi.org/10.5281/zenodo.17212097
Primary Topic
PI3K/AKT/mTOR signaling in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tamsulosin (Urimax) In Female Patient: A Case of Recurrent UTI and Left Pelvic Calculi

Zenodo (CERN European Organization for Nuclear Research)
PI3K/AKT/mTOR signaling in cancer
article

Tamsulosin (Urimax) In Female Patient: A Case of Recurrent UTI and Left Pelvic Calculi

article en

Abstract

Tamsulosin hydrochloride is a selective α1A-adrenergic receptor antagonist commonly used in the treatment of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland that can impede normal urinary flow in men. By selectively blocking α1A receptors predominantly located in the smooth muscle of the prostate and bladder neck, tamsulosin relaxes these muscles, thereby improving urine flow and reducing symptoms of urinary obstruction. Administered orally, typically in extended-release formulations, tamsulosin is well-tolerated, with common side effects including dizziness, abnormal ejaculation, and rhinitis. It is metabolized primarily by the liver via cytochrome P450 enzymes and excreted in the urine. By relaxing the smooth muscles in the urethral and bladder neck, tamsulosin can be used off-label to treat voiding dysfunctions in females, such as LUTS (Lower urinary tract symptoms), BOO (Bladder outlet obstruction), or urinary retention. It should be used on an individual basis and is frequently saved for particular situations when there aren't many other options.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 49%
PI3K/AKT/mTOR signaling in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Tamsulosin (Urimax) In Female Patient: A Case of Recurrent UTI and Left Pelvic Calculi · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS